(PARIS2024)FRANCE-PARIS-OLY-HANDBALL

(PARIS2024)FRANCE-PARIS-OLY-HANDBALL

(240729) -- PARIS, July 29, 2024 Photo by Xinhua/ABACAPRESS.COM) -- Sander Sagosen (R) of Norway vies against Ludovic Fabregas of France during the handball Men's Preliminary Round Group B match between France and Norway at Paris 2024 Olympic Games in Paris, France, July 29, 2024. Photo by Xinhua/ABACAPRESS.COM/Li Jing)

  • Product Code
  • ILEA003066713
  • Registered date
  • 2024/7/29 00:00:00
  • Credit
  • Abaca Press / Kyodo News Images
  • Media source
  • Xinhua/ABACA
  • Media size
  • 1882 × 1347 pixel
  • Resolution
  • 300 dpi
  • Deployment size
  • 1.97(MB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    China Launches 3 Astronauts To Tiangong Space Station

    China Launches 3 Astronauts To Tiangong Space Station

    This image captured at Beijing Aerospace Control Center on Oct. 30, 2024 shows a group photo of the crew of Shenzhou-18 and Shenzhou-19 manned spaceships. The three astronauts of China's Shenzhou-19 spaceflight mission have entered the Tiangong space station and met with another astronaut trio on Wednesday, starting a new round of in-orbit crew handover. The Shenzhou-18 crew opened the hatch at 12:51 p.m. (Beijing Time) and greeted the new arrivals, according to the China Manned Space Agency (CMSA). The six crew members then took group pictures for the fifth space get-together in China's aerospace history. They will live and work together for about five days to complete planned tasks and handover work, the CMSA said. The Shenzhou-18 crew is scheduled to return to the Dongfeng landing site in north China on Nov. 4. Photo by Li Jie/Xinhua/ABACAPRESS.COM
      China Launches 3 Astronauts To Tiangong Space Station

      China Launches 3 Astronauts To Tiangong Space Station

      This image captured at Beijing Aerospace Control Center on Oct. 30, 2024 shows the crew of Shenzhou-18 and Shenzhou-19 manned spaceships talking with each other. The three astronauts of China's Shenzhou-19 spaceflight mission have entered the Tiangong space station and met with another astronaut trio on Wednesday, starting a new round of in-orbit crew handover. The Shenzhou-18 crew opened the hatch at 12:51 p.m. (Beijing Time) and greeted the new arrivals, according to the China Manned Space Agency (CMSA). The six crew members then took group pictures for the fifth space get-together in China's aerospace history. They will live and work together for about five days to complete planned tasks and handover work, the CMSA said. The Shenzhou-18 crew is scheduled to return to the Dongfeng landing site in north China on Nov. 4. Photo by Li Jie/Xinhua/ABACAPRESS.COM
        Sanofi Group To Sell Doliprane To US Fund

        Sanofi Group To Sell Doliprane To US Fund

        Illustration of Doliprane in Paris, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Florian Poitout/ABACAPRESS.COM
          Sanofi Group To Sell Doliprane To US Fund

          Sanofi Group To Sell Doliprane To US Fund

          Illustration of Doliprane in Paris, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Florian Poitout/ABACAPRESS.COM
            Sanofi Group To Sell Doliprane To US Fund

            Sanofi Group To Sell Doliprane To US Fund

            Illustration of Doliprane in Paris, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Florian Poitout/ABACAPRESS.COM
              Sanofi Group To Sell Doliprane To US Fund

              Sanofi Group To Sell Doliprane To US Fund

              Illustration of Doliprane in Paris, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Florian Poitout/ABACAPRESS.COM
                Sanofi Group To Sell Doliprane To US Fund

                Sanofi Group To Sell Doliprane To US Fund

                Illustration of Doliprane in Paris, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Florian Poitout/ABACAPRESS.COM
                  Sanofi Group To Sell Doliprane To US Fund

                  Sanofi Group To Sell Doliprane To US Fund

                  Illustration of Doliprane in Paris, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Florian Poitout/ABACAPRESS.COM
                    Sanofi Group To Sell Doliprane To US Fund

                    Sanofi Group To Sell Doliprane To US Fund

                    Illustration of Doliprane in Paris, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Florian Poitout/ABACAPRESS.COM
                      Sanofi Group To Sell Doliprane To US Fund

                      Sanofi Group To Sell Doliprane To US Fund

                      Illustration of Doliprane in Paris, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Florian Poitout/ABACAPRESS.COM